Neuroblastoma Parent Global Symposium 2021

NPGS2021 and 2020 on-demand resource is available to access at www.nbparentsymposium.com

2021's focused on topics that affect many families within the neuroblastoma community, as well as featuring specialised conversation rooms for those who wish to discuss more specific interests. Over 20 experts were present and shared the latest updates in neuroblastoma research.

This was an absolutely fantastic event, very informative and excellently run. As a family member of someone with neuroblastoma, it was great to hear of the newer treatment options and hear survivor stories. Rosie, NPGS2020 Attendee

Solving Kids’ Cancer UK, the Children’s Neuroblastoma Cancer Foundation, and Solving Kids’ Cancer (US) have a long history of collaboration and partnership, as well as a wealth of experience in creating and hosting events to meet parent needs.

As neuroblastoma support and research charities we advocate passionately for children and families affected by neuroblastoma. The Neuroblastoma Parent Global Symposium 2021 will enable families, and all those who work to treat, help and support them, to access vital information, networking opportunities and share experience.

This event highlighted how well connected the oncology world is and that we are fortunate to have so many amazing experts around the globe searching for better treatments/cures for this devastating disease. Adam, NPGS2020 Attendee

We are proud to be working with our supporters GRC World Forums who are donating the event platform and technical expertise. We are also thankful to Y-mAbs Therapeutics, Jubilant, and Sanofi for their support in making this event possible!

About the organisers

Solving Kids’ Cancer UK

Solving Kids Cancer UK logo Solving Kids’ Cancer UK is a parent-led charity, our vision is a future where no child dies of neuroblastoma or suffers due to its treatment. We provide emotional and practical support to families and our research focus is on clinical trials, seeking to explore new ways of treating neuroblastoma, providing hope and options for children and their families now and in the future.

Children’s Neuroblastoma Cancer Foundation

The Children’s Neuroblastoma Cancer Foundation (CNCF) is the premier source for neuroblastoma information and resources.

Comprised of families just like yours, we are committed to finding a cure for neuroblastoma through research, education, awareness and advocacy. Visit www.cncfhope.org to find out more about the work of CNCF.

Solving Kids’ Cancer (US)

Solving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates—because Every Kid Deserves to Grow Up. Solving Kids' Cancer (SKC) helps accelerate clinical trials of next-generation treatments with an understanding of the global childhood cancer research landscape and current unmet needs. 

Latest

100 Miles for Jessica

To help raise money for critical treatment for Jessica Butler
Lucy’s Skydive for Jude

I am taking on this challenge to fundraise to help get my son, Jude, to target to access the bivalent vaccine in New York
Raffle for Jude

Jude is 4. He lives in Sheffield with his family. He is battling cancer & needs pioneering treatment in America. We can help get him there…
Rock N Roll for Kayla

Kayla from Norwich is facing a huge challenge, so rock n rollers unite.

Neuroblastoma Parent Global Symposium 2020

Neuroblastoma Parent Global Symposium 2020
2019 Neuroblastoma Parent Conference

2019 Solving Kids’ Cancer Neuroblastoma Parent Education Conference.
2018 Neuroblastoma Parent Education Conference

Our 2018 conference offered a concurrent session focusing on ways to deal with and manage the long-term side effects of neuroblastoma.
2017 Neuroblastoma Parent Education Conference

Our 6th Annual Neuroblastoma Parent Education Conference – ‘Understanding the Landscape of Neuroblastoma Research’
2016 Neuroblastoma Parent Education Conference

Our 5th Annual Neuroblastoma Parent Education Conference was held at Latimer Place in Chesham
2015 Neuroblastoma Parent Education Conference

Our 4th Annual Parent Conference was again held at Latimer Place, Chesham

Beau's Campaign

Beau was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in December 2020. Her family are appealing for your help to raise £317,000 by May 2022.
Flora's Campaign

In January 2021 Flora was diagnosed with Autism Spectrum Disorder, and just three months later her parents were given the devastating news she had high-risk neuroblastoma. Her family are appealing for your help to raise £252,000 by August 2022 for Flora to enrol on the Bivalent Vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Jude's Campaign

Jude is a Dinosaur and animal-loving three-year-old. In July 2021 Jude was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.
Joseph Yeandle

We are devastated to share the news that beautiful Joseph has sadly passed away.
Maysaa's Campaign

Four-year-old Maysaa was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in March 2021. Her family are asking for your support to raise £106,000 by August 2022 for Maysaa to enrol on the DFMO study in Charlotte that aims to stop her neuroblastoma from coming back.
Chloe’s Journey

Beautiful Chloe passed away on the 4th of February 2022.
Eden's Campaign

Six-year-old Eden was diagnosed with high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis, in April 2021.
Kayla's Campaign

Three-year-old Kayla was diagnosed with high-risk neuroblastoma in May 2021. Kayla’s parents are asking for your help to raise £221,000 by November 2022 for Kayla to enrol on the bivalent vaccine clinical trial in New York that aims to stop her neuroblastoma from coming back.
Peter's Campaign

11-year-old Peter was diagnosed with neuroblastoma in early 2019. Devastatingly he relapsed in August 2020 after being clear of disease for 6 months. Thanks to your incredible fundraising and support, Peter was able to enrol on the DFMO study in Charlotte at the end of January 2022.
Dulcie's Campaign

In December 2021, five-year-old Dulcie was diagnosed with high-risk neuroblastoma, a rare and aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis.